SCHEMBL3093350

SCHEMBL3093350

C=CCOC[C@@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6013926 1.00
SCHEMBL30534 1.00
SCHEMBL5925041 0.98 CA1 (0.63)
SCHEMBL291913 0.98 CA1 (0.63)
Hydrogen Sulfide SCHEMBL27334247 0.98 CA1 (0.63)
SCHEMBL8754223 0.98 CA1 (0.63)
Methane SCHEMBL27945377 0.98 CA1 (0.63)
SCHEMBL13755789 0.96 CA1 (0.61)
SCHEMBL9816229 0.96 CA1 (0.61)
SCHEMBL13755787 0.96 CA1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160187339-A1 Biomarker and Method for Determining an Oxidative Stress Level BIOCRATES LIFE SCIENCES AG (AT) 2016-06-30 US claimed
US-20130065265-A1 Biomarker and Method for Determining an Oxidative Stress Level BIOCRATES LIFE SCIENCES AG (AT) 2013-03-14 US claimed
US-20100173342-A1 Biomarker and Method for Determining an Oxidative Stress Level BIOCRATES LIFE SCIENCES AG (AT) 2010-07-08 US claimed
US-5047563-A Ionophores MILES INC. (US) 1991-09-10 US claimed
US-20260034106-A1 Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics UNIV DARMSTADT TECH (DE) 2026-02-05 US disclosed
EP-4686495-A1 MACROCYCLIC LIGANDS FOR FK506-BINDING PROTEINS FOR TREATMENT OF DISEASES WITH IMPROVED CHARACTERISTICS Technische Universität Darmstadt (DE) 2026-02-04 EP disclosed
US-20160187339-A1 Biomarker and Method for Determining an Oxidative Stress Level BIOCRATES LIFE SCIENCES AG (AT) 2016-06-30 US disclosed
US-20130065265-A1 Biomarker and Method for Determining an Oxidative Stress Level BIOCRATES LIFE SCIENCES AG (AT) 2013-03-14 US disclosed
US-20100173342-A1 Biomarker and Method for Determining an Oxidative Stress Level BIOCRATES LIFE SCIENCES AG (AT) 2010-07-08 US disclosed
US-20090004706-A1 METHODS TO ENHANCE THE ACTIVITY OF LIGNOCELLULOSE-DEGRADING ENZYMES ATHENIX CORPORATION (US) 2009-01-01 US disclosed
US-20090004692-A1 METHODS TO ENHANCE THE ACTIVITY OF LIGNOCELLULOSE-DEGRADING ENZYMES ATHENIX CORPORATION (US) 2009-01-01 US disclosed
US-20090004698-A1 METHODS TO ENHANCE THE ACTIVITY OF LIGNOCELLULOSE-DEGRADING ENZYMES ATHENIX CORPORATION (US) 2009-01-01 US disclosed
US-5133934-A Enantiomorphs of bis/12-crown-4-methyl/ dialkyl malonate, a carrier and ionophore MILES INC. (US) 1992-07-28 US disclosed
US-5047563-A Ionophores MILES INC. (US) 1991-09-10 US disclosed
EP-0240398-B1 DISSYMMETRICAL 1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC-ACID DERIVATIVES, PREPARATION PROCESSES AND THERAPEUTICAL USE FOURNIER INNOVATION ET SYNERGIE (FR) 1991-05-15 EP disclosed
EP-0306802-B1 CHIRAL CROWN ETHERS MILES INC. (US) 1991-05-15 EP disclosed
US-4900833-A HYPOTENSIVE AGENTS SOCIETE DE RECHERCHES INDUSTRIES (S.O.R.I.) (FR) 1990-02-13 US disclosed
EP-0306802-A1 Chiral crown ethers MILES INC. (US) 1989-03-15 EP disclosed
US-4806544-A ENANTIOMORPHS, RACEMIC MIXTURES, HYPOTENSIVE AGENTS, CARDIOV LAR DISORDERS FOURNIER INNOVATION ET SYNERGIE (FR) 1989-02-21 US disclosed
EP-0240398-A1 Dissymmetrical 1,4-dihydropyridine-3,5-dicarboxylic-acid derivatives, preparation processes and therapeutical use FOURNIER INNOVATION ET SYNERGIE (FR) 1987-10-07 EP disclosed